HIZENTRA GODISC Trademark

Trademark Overview


On Monday, September 23, 2019, a trademark application was filed for HIZENTRA GODISC with the United States Patent and Trademark Office. The USPTO has given the HIZENTRA GODISC trademark a serial number of 88626473. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 6, 2023. This trademark is owned by CSL Behring AG. The HIZENTRA GODISC trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for the treatment of immunodeficiency disorders; Pharmaceutical preparations for the treatment of chronic inflammatory demyelinating polyneuropathy and primary immunodeficiency; pharmaceutical preparations in the nature of intravenous immunoglobulins for use in the treatment of immunodeficiency disorders and in immune replacement therapy

Surgical and medical apparatus and instruments for subcutaneous treatment, namely, for the administration of subcutaneous therapy; Medical devices for the administration of subcutaneous therapy for use in treating immunodeficiency disorders; Surgical instruments for use in the administration of subcutaneous medicine; medical instruments for use in the administration of subcutaneous infusion of medicine; Medical apparatus and instruments for use in subcutaneous medical procedures; Medical devices for the administration of subcutaneous therapy, namely, medical devices for accessing subcutaneous structures of the human body for the purpose of administering medical treatment
hizentra godisc

General Information


Serial Number88626473
Word MarkHIZENTRA GODISC
Filing DateMonday, September 23, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 6, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of immunodeficiency disorders; Pharmaceutical preparations for the treatment of chronic inflammatory demyelinating polyneuropathy and primary immunodeficiency; pharmaceutical preparations in the nature of intravenous immunoglobulins for use in the treatment of immunodeficiency disorders and in immune replacement therapy
Goods and ServicesSurgical and medical apparatus and instruments for subcutaneous treatment, namely, for the administration of subcutaneous therapy; Medical devices for the administration of subcutaneous therapy for use in treating immunodeficiency disorders; Surgical instruments for use in the administration of subcutaneous medicine; medical instruments for use in the administration of subcutaneous infusion of medicine; Medical apparatus and instruments for use in subcutaneous medical procedures; Medical devices for the administration of subcutaneous therapy, namely, medical devices for accessing subcutaneous structures of the human body for the purpose of administering medical treatment

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 27, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, September 27, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCSL Behring AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBern CH-3000
CH

Party NameCSL Behring AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBern CH-3000
CH

Trademark Events


Event DateEvent Description
Monday, November 6, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 6, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 1, 2023SOU EXTENSION 5 GRANTED
Monday, February 6, 2023SOU EXTENSION 5 FILED
Wednesday, February 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 6, 2022SOU EXTENSION 4 GRANTED
Tuesday, September 6, 2022SOU EXTENSION 4 FILED
Tuesday, September 6, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 9, 2022ASSIGNED TO EXAMINER
Monday, March 7, 2022SOU EXTENSION 3 GRANTED
Monday, March 7, 2022SOU EXTENSION 3 FILED
Monday, March 7, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 7, 2021SOU EXTENSION 2 GRANTED
Tuesday, September 7, 2021SOU EXTENSION 2 FILED
Tuesday, September 7, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, March 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 8, 2021SOU EXTENSION 1 GRANTED
Monday, March 8, 2021SOU EXTENSION 1 FILED
Monday, March 8, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 6, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 11, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 7, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 6, 2020ASSIGNED TO LIE
Wednesday, June 24, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 24, 2019NON-FINAL ACTION E-MAILED
Tuesday, December 24, 2019NON-FINAL ACTION WRITTEN
Tuesday, December 24, 2019ASSIGNED TO EXAMINER
Friday, September 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 26, 2019NEW APPLICATION ENTERED